Revance Therapeutics shares owned by Capital Fund Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Capital Fund Management
from 13F filings
Historical chart of Capital Fund Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Capital Fund Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $900k | 79k | 11.47 |
2023-06-30 | $739k | 29k | 25.31 |
2022-12-31 | $312k | 17k | 18.46 |
2020-09-30 | $351k | 14k | 25.14 |